Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:52:55.267Z.
Calculation as of: 2026-10-06T17:52:55.267Z.
Quote observation: 2026-10-06T17:50:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 64600f38e310d2eb3cd81a0b95bf77f6abd31b9de5548b9cdd3f3c9d46967593
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
PROCEPT BioRobotics Corporation
Market Cap
$983.52M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$983.98M
EV/EBIT Ratio
5.18x
TTM Avg
6.47x
3Y Avg
6.47x
5Y Avg
6.47x
Market Cap
$979.11M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$993.25M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$971.38M
EV/EBIT Ratio
63.84x
TTM Avg
51.40x
3Y Avg
38.19x
5Y Avg
39.85x
Market Cap
$1.01B
EV/EBIT Ratio
N/A
TTM Avg
2.12x
3Y Avg
2.12x
5Y Avg
2.12x
Market Cap
$949.90M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $983.52M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $983.98M | 5.18x | 6.47x | 6.47x | 6.47x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.11M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $993.25M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $971.38M | 63.84x | 51.40x | 38.19x | 39.85x |
| Vor Biopharma Inc. (VOR)vs › | $997.03M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $968.25M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | 2.12x | 2.12x | 2.12x |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $949.90M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $949.84M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
